The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.

Feldman, B M; Aledort, L; Bullinger, M; Delaney, F M; Doria, A S; Funk, S; Giangrande, P; Lundin, B; Manco-Johnson, M; Miners, A; Scriba, P C; Srivastava, A; Schramm, W; Blanchette, V S

Feldman, B M; Aledort, L; Bullinger, M; Delaney, F M; Doria, A S; Funk, S; Giangrande, P; Lundin, B; Manco-Johnson, M; Miners, A; Scriba, P C; Srivastava, A; Schramm, W; Blanchette, V S.

Afiliação

Feldman BM; Department of Pediatrics, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada. brian.feldman@sickkids.ca

Haemophilia ; 13(6): 745-9, 2007 Nov.

Article em En | MEDLINE | ID: mdl-17850325

Assuntos

Hemofilia A/economia; Hemofilia A/prevenção & controle; Análise Custo-Benefício; Política de Saúde; Hemofilia A/terapia; Humanos; Seguro Saúde; América do Norte; Reino Unido

Buscar no Google

Imprimir

XML

PubMed Links